Prolia (Denosumab)
- Medicine Name: Prolia
- API: Denosumab
- Dosage Form & Strength: Injection: Single-dose prefilled syringe containing 60 mg in a 1 mL solution
- Manufactured By: Amgen Inc.
- Prolia is a RANK ligand (RANKL) inhibitor used for the treatment:
- of postmenopausal females with osteoporosis at high risk for fracture
- to increase bone mass in males with osteoporosis at high risk for fracture
- of glucocorticoid-induced osteoporosis in males and females at high risk for fracture
- to increase bone mass in males at high risk for fracture receiving androgen deprivation therapy for nonmetastatic prostate cancer
- to increase bone mass in females at high risk for fracture receiving adjuvant aromatase inhibitor therapy for breast cancer
Recommended Dosage: The recommended dose of Prolia injection is 60 mg administered as a single subcutaneous injection once every 6 months. To administer Prolia, inject it subcutaneously into the upper arm, upper thigh, or abdomen. Patients should also take 1000 mg of calcium and at least 400 IU of vitamin D daily.
If a dose of Prolia is missed, give the injection as soon as possible. Then, continue injections every 6 months from the date of the last one.
- Severe hypocalcemia can occur due to Prolia usage. Prior to initiating Prolia therapy, it’s essential to address any existing hypocalcemia. Additionally, assess patients for chronic kidney disease mineral-bone disorder and regularly monitor serum calcium levels.
- Since Prolia and Xgeva both contain denosumab, patients who are being treated with Prolia 60 mg injection should avoid receiving Xgeva.
- Prolia may cause severe hypersensitivity reactions, including anaphylaxis. Symptoms can include low blood pressure, difficulty breathing, tightness in the throat, itching, and hives. If an allergic reaction occurs, seek medical attention promptly and stop using Prolia.
- After stopping Prolia treatment, there is an increased risk of fractures, particularly multiple vertebral fractures. These new fractures can occur as soon as 7 months (on average 19 months) after the last dose. Prior vertebral fracture increases the likelihood of experiencing multiple vertebral fractures after stopping Prolia. It’s important to carefully consider the benefits and risks for each individual before starting Prolia treatment.
- Patients taking Prolia may experience severe and sometimes debilitating bone, joint, and/or muscle pain. Symptoms can appear as early as one day or as late as several months after starting treatment. If severe symptoms occur, it may be advisable to discontinue Prolia use.
What documents are required to import PROLIA to India?
PROLIA (denosumab) injections can be imported by patients or government hospitals on the name of the patients only.
The following documentation is required to import the product:
- A valid prescription from a qualified doctor.
- Patients diagnostic reports
- Patients ID proof (issued by the government of India)
How does the order be confirmed?
The order will be confirmed only after the receipt of:
- A valid prescription from Doctor
- Import permit if applicable
Is PROLIA available in India?
PROLIA (denosumab injection) is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.
IPN (Indian Pharma Network) helps import cancer medicines on the named patient supply (NPS). Indian Pharma Network is the facilitator providing input
- On availability of Prolia in India (Mumbai, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Pune etc.)
- Medicine Price.
- Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia
- Ensuring 100% transparency.
PROLIA can be made available to patients, doctors, and hospitals in Mumbai, Goa, Kolkata, Hyderabad, Chennai, Ahmedabad, Delhi, Bangalore, Srinagar, Jammu, Jaipur, Chandigarh, Ludhiana, Noida, Gurgaon, Lucknow, and Pune and other cities in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.
IPN (Indian Pharma Network) can facilitate the supply of PROLIA (prescription medicines) to all locations in the world and in India after fulfilling the legal requirement (if applicable).
Please contact +91-9310090915 | Toll-Free Number: 1800-889-1064 or write us at info@indianpharmanetwork.in for Prolia (denosumab) price in India.
We take to guarantee quality and delivery anywhere in the world as per the buyer’s requirements.
Indian Pharma Network is able to source the PROLIA (Cancer Treatment Medicines) from across the globe and has the ability to supply. Indian Pharma offers its customers worldwide access to the best available treatment.
Indian Pharma Network is able to dispense any valid prescription in the shortest possible time. All prescriptions are dispensed and checked by registered pharmacists and dispatched to the Patient’s address only from New Delhi, India.
What is the Generic Name for the trade name drug Prolia®?
Denosumab is a Generic Name for the trade name drug Prolia®.
What is the Manufacturer’s Name of Prolia®?
Prolia® is manufactured by Amgen Inc.
Is Prolia® approved by the FDA?
Yes, Prolia® is approved by the FDA. Date of first approval: June 1, 2010.
Where can I get Prolia® at the best price in India?
To get the best Prolia price in India, kindly contact the Indian Pharma Network (a WHO GDP and ISO 9001:2008 certified company). For Prolia®, a medical prescription is needed from a treating physician.
What is the dosage and form of Prolia® supplied?
Prolia® is supplied as an Injection: A single-dose prefilled syringe containing 60 mg in a 1 mL solution for subcutaneous use.
How much does Prolia cost in India?
The cost of Prolia in India can vary. To procure this medicinal product legally, you can call or WhatsApp +91-9310090915 or send mail to info@indianpharmanetwork.in.
What are the storage conditions of Prolia®?
Prolia® should be stored in the refrigerator at a temperature between 36°F to 46°F (2°C to 8°C).
Is it safe to buy Prolia® online in India?
Yes, one can buy Prolia online in India at the lowest price from the Indian Pharma Network (IPN) if this medicinal product is not (yet) registered or available in their country. We can help facilitate the supply of Prolia injections through legal channels.
Contact Patient Support
If you have any questions or need any help, contact our Patient Support Team. We will get in touch with you within 24 hours from Monday to Friday between 9:00 and 10:00 CET.
Disclaimer
All Trademarks and Brands that appear on the website belong to their respective owners and indianpharmanetwork does not lay any claim on them we only provide Information.